These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18563070)

  • 41. [Strategy for development of imaging biomarkers].
    Ishiwata K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):67-71. PubMed ID: 19562944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical cardiovascular molecular imaging.
    Bengel FM
    J Nucl Med; 2009 Jun; 50(6):837-40. PubMed ID: 19443581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Development of in vivo imaging system targeting a molecular marker].
    Furukawa T
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1269-71. PubMed ID: 18701835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of modeling and simulation to integrate clinical pharmacology knowledge across a new drug application.
    Gobburu JV; Sekar VJ
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):281-8. PubMed ID: 12139204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor models and specific contrast agents for small animal imaging in oncology.
    Ni Y; Wang H; Chen F; Li J; DeKeyzer F; Feng Y; Yu J; Bosmans H; Marchal G
    Methods; 2009 Jun; 48(2):125-38. PubMed ID: 19328231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 'Two is better than one'--probes for dual-modality molecular imaging.
    Jennings LE; Long NJ
    Chem Commun (Camb); 2009 Jun; (24):3511-24. PubMed ID: 19521594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular imaging in drug development.
    Willmann JK; van Bruggen N; Dinkelborg LM; Gambhir SS
    Nat Rev Drug Discov; 2008 Jul; 7(7):591-607. PubMed ID: 18591980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations.
    Gabrielsson J; Dolgos H; Gillberg PG; Bredberg U; Benthem B; Duker G
    Drug Discov Today; 2009 Apr; 14(7-8):358-72. PubMed ID: 19162219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.
    Desar IM; van Herpen CM; van Laarhoven HW; Barentsz JO; Oyen WJ; van der Graaf WT
    Cancer Treat Rev; 2009 Jun; 35(4):309-21. PubMed ID: 19136215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers to clinical translation with diagnostic drugs.
    Josephson L; Rudin M
    J Nucl Med; 2013 Mar; 54(3):329-32. PubMed ID: 23359658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developing new molecular imaging probes for PET.
    Serdons K; Verbruggen A; Bormans GM
    Methods; 2009 Jun; 48(2):104-11. PubMed ID: 19318126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of pharmacogenetics in treating central nervous system disorders.
    Patnaik M; Renda MJ; Athanasiou MC; Reed CR
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1504-9. PubMed ID: 18849543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An update survey of academic radiologists' clinical productivity.
    Lu Y; Zhao S; Chu PW; Arenson RL
    J Am Coll Radiol; 2008 Jul; 5(7):817-26. PubMed ID: 18585659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular imaging to biomarker development in neuroscience.
    Frost JJ
    Ann N Y Acad Sci; 2008 Nov; 1144():251-5. PubMed ID: 19076382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
    Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
    J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The exploratory IND.
    Mills G
    J Nucl Med; 2008 Jun; 49(6):45N-47N. PubMed ID: 18511824
    [No Abstract]   [Full Text] [Related]  

  • 57. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature.
    Narendran R; Martinez D
    Synapse; 2008 Nov; 62(11):851-69. PubMed ID: 18720516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment.
    Showalter HD; Denny WA
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S3-17. PubMed ID: 18762151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.